This is not the most recent version of the article. View current version (8 FEB 2016)

Intervention Review

You have free access to this content

Antithrombin III for critically ill patients

  1. Arash Afshari1,*,
  2. Jørn Wetterslev2,
  3. Jesper Brok3,
  4. Ann Merete Møller4

Editorial Group: Cochrane Anaesthesia, Critical and Emergency Care Group

Published Online: 16 JUL 2008

Assessed as up-to-date: 4 NOV 2006

DOI: 10.1002/14651858.CD005370.pub2


How to Cite

Afshari A, Wetterslev J, Brok J, Møller AM. Antithrombin III for critically ill patients. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD005370. DOI: 10.1002/14651858.CD005370.pub2.

Author Information

  1. 1

    Rigshospitalet, The Cochrane Anaesthesia Review Group & Copenhagen Trial Unit and Department of Paediatric and Obstetric Anaesthesia, Copenhagen, Denmark

  2. 2

    Rigshospitalet, Copenhagen University Hospital, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Copenhagen, Denmark

  3. 3

    Rigshospitalet, Paediatric Department 4072, Copenhagen, Denmark

  4. 4

    Herlev University Hospital, The Cochrane Anaesthesia Review Group, Rigshospitalet & Department of Anaesthesiology, Herlev, Denmark

*Arash Afshari, The Cochrane Anaesthesia Review Group & Copenhagen Trial Unit and Department of Paediatric and Obstetric Anaesthesia, Rigshospitalet, Blegdamsvej 9, Afsnit 3342, rum 52, Copenhagen, 2100, Denmark. arriba.a@gmail.com. afshari@rocketmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 16 JUL 2008

SEARCH

This is not the most recent version of the article. View current version (08 FEB 2016)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stefano Romagnoli, Alessandra Rizza, Zaccaria Ricci, Fluid Status Assessment and Management during the Perioperative Phase in Adult Cardiac Surgery Patients, Journal of Cardiothoracic and Vascular Anesthesia, 2015,

    CrossRef

  2. 2
    Ghada M. N. Bashandy, Implications of recent accumulating knowledge about endothelial glycocalyx on anesthetic management, Journal of Anesthesia, 2015, 29, 2, 269

    CrossRef

  3. 3
    Nitin Seam, Anthony F Suffredini, Is antithrombin treatment of disseminated intravascular coagulation a quixotic goal?, Critical Care, 2014, 18, 6

    CrossRef

  4. 4
    Lorenzo A. Orci, Stéphanie Lacotte, Graziano Oldani, Philippe Morel, Gilles Mentha, Christian Toso, The Role of Hepatic Ischemia–Reperfusion Injury and Liver Parenchymal Quality on Cancer Recurrence, Digestive Diseases and Sciences, 2014, 59, 9, 2058

    CrossRef

  5. 5
    Janet M Lord, Mark J Midwinter, Yen-Fu Chen, Antonio Belli, Karim Brohi, Elizabeth J Kovacs, Leo Koenderman, Paul Kubes, Richard J Lilford, The systemic immune response to trauma: an overview of pathophysiology and treatment, The Lancet, 2014, 384, 9952, 1455

    CrossRef

  6. 6
    Kyoung-Ah Kim, Yoon-Young Lim, Sun-Ho Kim, Ji-Young Park, Bioequivalence of Two Intravenous Formulations of Antithrombin III: A Two-Way Crossover Study in Healthy Korean Subjects, Clinical Therapeutics, 2013, 35, 11, 1752

    CrossRef

  7. 7
    Matteo Bruschettini, Olga Romantsik, Simona Zappettini, Rita Banzi, Luca Antonio Ramenghi, Maria Grazia Calevo, Antithrombin for the prevention of intraventricular hemorrhage in very preterm infants, The Cochrane Library,
  8. 8
    Mikkel Allingstrup, Jørn Wetterslev, Frederikke B Ravn, Ann Merete Møller, Arash Afshari, Antithrombin III for critically ill patients, The Cochrane Library,